Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

758.27
+7.761.03%
Post-market: 759.060.7900+0.10%18:15 EDT
Volume:872.42K
Turnover:659.47M
Market Cap:78.07B
PE:18.75
High:763.72
Open:749.84
Low:742.94
Close:750.51
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.13
T/O Rate:0.88%
Dividend:3.64
Dividend Rate:0.48%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.46
PE(LYR):18.28

Loading ...

Sep 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2026

Major Issues Report

Form 8-K - Current report
Apr 08, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 30, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report